NPD
This article was originally published in The Rose Sheet
Executive Summary
Market View Current Conditions Report, launching now, provides NPD clients "deeper insight" into the prestige beauty market with national and regional information as well as new measures such as sales rates and distribution, according to an Aug. 5 release from the beauty market research company. "With more granular sales data, manufacturers and their retail partners can better understand their consumers and develop, monitor and improve marketing and sales efficiencies," says Diane Nicholson, president, Beauty, The NPD Group. Based on data provided by participating retailers on a weekly basis, NPD's report gives clients a monthly view of new information so they can "refine their sell-in strategies, discover regional opportunities, and understand how distribution and sales rates impact market share," firm notes
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.